Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Longitudinal Study of CA 15-3 as an Aid in Monitoring Recurrence or Progressive Disease in Patients With Breast Cancer

NCT02270931 is registered in ClinicalTrials.gov with Fujirebio Diagnostics, Inc. as lead sponsor.

NCT NCT02270931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02270931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Longitudinal Study of CA 15-3 as an Aid in Monitoring Recurrence or Progressive Disease in Patients With Breast Cancer
Lead sponsor
Fujirebio Diagnostics, Inc.
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
June 30, 2021
Enrollment
130 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer